Undervalued Dividend Growth Stock of the Week: Pfizer (PFE)
With a market-smashing yield, inflation-beating dividend growth, and the potential that shares are 26% undervalued, long-term dividend growth investors who like a contrarian, reversion-to-mean play have a prime candidate here.
Read More